Ebola virus disease (EVD), formerly known as Ebola haemorrhagic fever, is a severe, it is fatal disease in humans. The virus is transfer to people from wild animals and spreads in the human population through human-to-human transmission.
A member of Russian scientists has developed a vaccine against the deadly Ebola virus and its trials are due to be completed in February, officials said Monday. The scientists belong to St. Petersburg’s Research Institute of Influenza. ‘The vaccine against Ebola created by a group of young scientists is undergoing tests for genetic stability,’ the official said, adding that the vaccine will be called “candidate” until its industrial production begins.
The vaccine of this has already been sent to the Virology Centre of the defence ministry and will be first tested on animals. The clinical tests also going through on this diseases people involving are all volunteers, on them tests will be conducted in Africa. , The official added, all the stages of the trials are due to wrap up in February.
According to the latest figures by the World Health Organisation (WHO) show that the toll from the current Ebola outbreak has reached 7,693 and 19,695 people have been infected. Most of the deaths were reported in the hardest-hit West African countries of Liberia, Sierra Leone and Guinea.